136 related articles for article (PubMed ID: 37464836)
1. Development of Dual Inhibitors of Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase with Tetrazole Core.
Mehrandish S; Rezaee E; Sedaghat A; Heidarli E; Naderi N; Tabatabai SA
Med Chem; 2023; 19(10):1037-1048. PubMed ID: 37464836
[TBL] [Abstract][Full Text] [Related]
2. Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.
Wilt S; Kodani S; Valencia L; Hudson PK; Sanchez S; Quintana T; Morisseau C; Hammock BD; Kandasamy R; Pecic S
Bioorg Med Chem; 2021 Dec; 51():116507. PubMed ID: 34794001
[TBL] [Abstract][Full Text] [Related]
3. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
[TBL] [Abstract][Full Text] [Related]
4. Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors.
Kodani SD; Wan D; Wagner KM; Hwang SH; Morisseau C; Hammock BD
ACS Omega; 2018 Oct; 3(10):14076-14086. PubMed ID: 30411058
[TBL] [Abstract][Full Text] [Related]
5. Quinolinyl-based multitarget-directed ligands with soluble epoxide hydrolase and fatty acid amide hydrolase inhibitory activities: Synthetic studies and pharmacological evaluations.
Angelia J; Duong L; Yun F; Mesic A; Yuan C; Carr D; Gunari S; Hudson PK; Morisseau C; Hammock BD; Kandasamy R; Pecic S
Heliyon; 2024 Jun; 10(11):e32262. PubMed ID: 38912512
[TBL] [Abstract][Full Text] [Related]
6. Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive.
Sasso O; Wagner K; Morisseau C; Inceoglu B; Hammock BD; Piomelli D
Pharmacol Res; 2015 Jul; 97():7-15. PubMed ID: 25882247
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones.
Jaiswal S; Akhilesh ; Uniyal A; Tiwari V; Raja Ayyannan S
Bioorg Med Chem; 2022 Apr; 60():116698. PubMed ID: 35296453
[TBL] [Abstract][Full Text] [Related]
8. Discovery of benzamide derivatives containing urea moiety as soluble epoxide hydrolase inhibitors.
Tian Y; Li S; Dong K; Su X; Fu S; Lv X; Duan M; Yang T; Han Y; Hu G; Liu J; Sun Y; Yue H; Sun Y; Zhang H; Du Z; Miao Z; Tong M; Liu Y; Qin M; Gong P; Hou Y; Gao Z; Zhao Y
Bioorg Chem; 2022 Oct; 127():105898. PubMed ID: 35792317
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of 4-benzamidobenzoic Acid hydrazide derivatives as novel soluble epoxide hydrolase inhibitors.
Rezaee Zavareh E; Hedayati M; Hoghooghi Rad L; Shahhosseini S; Faizi M; Tabatabai SA
Iran J Pharm Res; 2014; 13(Suppl):51-9. PubMed ID: 24711829
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of carbamate derivatives as fatty acid amide hydrolase and monoacylglycerol lipase inhibitors.
Jaiswal S; Gupta G; Ayyannan SR
Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200081. PubMed ID: 35924298
[TBL] [Abstract][Full Text] [Related]
11. Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors.
Rezaee E; Amrolah SM; Nazari M; Tabatabai SA
Mol Divers; 2021 Feb; 25(1):45-53. PubMed ID: 31873869
[TBL] [Abstract][Full Text] [Related]
12. Scaffold hopping-guided design of some isatin based rigid analogs as fatty acid amide hydrolase inhibitors: Synthesis and evaluation.
Jaiswal S; Tripathi RKP; Ayyannan SR
Biomed Pharmacother; 2018 Nov; 107():1611-1623. PubMed ID: 30257379
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Docking Study and Biological Evaluation of Amide-Based Soluble Epoxide Hydrolase Inhibitors with Novel Secondary Pharmacophore of Pyrimidin-2-ol.
Hejazi L; Ebadi A; Fakhar Z; Nazari M; Rezaee E; Abbas Tabatabai S
Chem Biodivers; 2022 Nov; 19(11):e202200231. PubMed ID: 36152343
[TBL] [Abstract][Full Text] [Related]
14. Discovery of phthalimide derivatives as novel inhibitors of a soluble epoxide hydrolase.
Mahlooji I; Shokri M; Manoochehri R; Mahboubi-Rabbani M; Rezaee E; Tabatabai SA
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000052. PubMed ID: 32484272
[TBL] [Abstract][Full Text] [Related]
15. Development of multitarget inhibitors for the treatment of pain: Design, synthesis, biological evaluation and molecular modeling studies.
Wilt S; Kodani S; Le TNH; Nguyen L; Vo N; Ly T; Rodriguez M; Hudson PK; Morisseau C; Hammock BD; Pecic S
Bioorg Chem; 2020 Oct; 103():104165. PubMed ID: 32891856
[TBL] [Abstract][Full Text] [Related]
16. Soluble epoxide hydrolase inhibitors: an overview and patent review from the last decade.
Iyer MR; Kundu B; Wood CM
Expert Opin Ther Pat; 2022 Jun; 32(6):629-647. PubMed ID: 35410559
[TBL] [Abstract][Full Text] [Related]
17.
Sedaghat A; Rezaee E; Hosseini O; Tabatabai SA
Iran J Pharm Res; 2020; 19(4):103-112. PubMed ID: 33841526
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of substituted fluorobenzimidazoles as inhibitors of 5-lipoxygenase and soluble epoxide hydrolase for anti-inflammatory activity.
Nandha B; Ramareddy SA; Kuntal H
Arch Pharm (Weinheim); 2018 Jun; 351(6):e1800030. PubMed ID: 29732612
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship studies of benzothiazole-phenyl analogs as multi-target ligands to alleviate pain without affecting normal behavior.
Angelia J; Weng X; Solomatov A; Chin C; Fernandez A; Hudson PK; Morisseau C; Hammock BD; Kandasamy R; Pecic S
Prostaglandins Other Lipid Mediat; 2023 Feb; 164():106702. PubMed ID: 36529320
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel heterocyclic amide-based inhibitors: an integrative
Fakhar Z; Hejazi L; Tabatabai SA; Munro OQ
J Biomol Struct Dyn; 2022 Sep; 40(15):7114-7128. PubMed ID: 33650467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
